Evidence-aware
Safety focused
Women’s Health Clinic FAQ
Can the O-Shot help stress incontinence?
The O-Shot is sometimes discussed for stress urinary incontinence, especially milder leakage linked with urethral support and pelvic-floor factors, but it needs careful expectation setting.
Direct answer
The O-Shot is sometimes discussed for stress urinary incontinence, especially milder leakage linked with urethral support and pelvic-floor factors, but it needs careful expectation setting.
The most useful plan starts with the underlying cause, not the treatment name. Your clinician should review symptoms, medical history, alternatives, expected benefits, limitations and safety.
Educational only. Suitability must be confirmed after consultation. Results vary. Not a cure.
At a glance
These are the main points to understand before deciding whether this option is suitable.
At a glance
Clinical summary
Mechanism
PRP utilizes a concentration of platelets derived from the patient's own blood, which release growth factors to promote.
Application
The plasma is injected into the anterior vaginal wall and periurethral tissues to improve urethral support and sphincter.
Efficacy
Studies show significant short-term reductions in urinary leakage episodes and improvements in quality of life scores [9-11].
Suitability must be confirmed after consultation.
Suitability must be confirmed after consultation.
Important safety note
Safety Profile: Because PRP uses autologous (the patient's own) blood, there is a minimal risk of allergic reaction or foreign body rejection [5, 18].
Suitability
Evidence
Safety
Aftercare
Detailed answer
Detailed answer
Patient Selection: PRP shows the more consistent reported response in women with mild to moderate SUI [1, 2].
Clinical context
Patient Selection: PRP shows the more consistent reported response in women with mild to moderate SUI [1, 2].
Evidence
Symptoms
Alternatives
What it means
Patient Selection: PRP shows the more consistent reported response in women with mild to moderate SUI [1, 2].
Why it happens
Regulatory Stance: Leading health bodies (such as the NHS, NICE, and RCOG) do not currently endorse PRP as a standard treatment for SUI, recommending instead that patients first.
Evidence limits
Evidence Limitations: While short-term outcomes are early, the treatment lacks large-scale, long-term randomised controlled trials to confirm durability, and results can vary significantly among individuals [27, 28].
Treatment fit
Suitability depends on history, symptoms, examination where appropriate and discussion of alternatives.
What this means in practice
Setting: It is an outpatient, office-based procedure available primarily through private aesthetic, cosmetic, or women's wellness clinics [29, 30]. Costs should be confirmed on the /pricing/ page before booking
Procedure Duration: The entire process, including the blood draw, centrifugation, and injection, takes approximately 30 to 45 minutes [12, 13].
Patient safety
Why proper assessment matters
Assessment helps separate marketing claims from safe, individualised clinical decision-making.
It checks the cause
Patient Selection: PRP shows the more consistent reported response in women with mild to moderate SUI [1, 2].
It protects safety
Safety Profile: Because PRP uses autologous (the patient's own) blood, there is a minimal risk of allergic reaction or foreign body rejection [5, 18].
It reviews alternatives
Setting: It is an outpatient, office-based procedure available primarily through private aesthetic, cosmetic, or women's wellness clinics [29, 30].
It sets expectations
Procedure Duration: The entire process, including the blood draw, centrifugation, and injection, takes approximately 30 to 45 minutes [12, 13].
A clinical decision, not a shortcut
The safest final page should explain what the intervention may do, what it cannot promise, and when another route may be better.
Treatment should be discussed with realistic goals, informed consent, clear aftercare and a plan for review.
Considerations
What to consider
Setting: It is an outpatient, office-based procedure available primarily through private aesthetic, cosmetic, or women's wellness clinics [29, 30]. Costs should be confirmed on the /pricing/ page before booking
Consultation priorities
Consultation & Preparation: A clinician will review your medical history and pelvic health.
Consent
Aftercare
Follow-up
Before treatment
Consultation & Preparation: A clinician will review your medical history and pelvic health.
During care
Blood Draw & Processing: A small sample of venous blood (approx.
Aftercare
Numbing: A topical local anaesthetic cream (or local nerve block) is applied to the vaginal, periurethral, and clitoral areas to minimise discomfort [7, 18, 41].
When to reassess
Injection: The PRP is precisely injected into targeted areas using an ultra-fine needle, usually taking only 5 to 10 minutes [7, 40, 41].
Practical expectations
Procedure Duration: The entire process, including the blood draw, centrifugation, and injection, takes approximately 30 to 45 minutes [12, 13].
Costs should be confirmed on the /pricing/ page before booking
Common concerns and myths
Common misconceptions
Clear patient information should correct over-simple claims and keep expectations realistic.
Myth: Stress incontinence is the same as urge incontinence.
Reality: suitability depends on the symptom pattern, medical history, contraindications, alternatives and individual goals.
Myth: Mild and severe leakage need the same pathway.
Reality: results vary, evidence may be developing, and non-response should prompt reassessment.
Myth: PRP is a replacement for assessment or pelvic-floor care.
Reality: injections, devices and intimate procedures can still carry risks and need proper consent and aftercare.
Evidence and advertising
Regulatory Stance: Leading health bodies (such as the NHS, NICE, and RCOG) do not currently endorse PRP as a standard treatment for SUI, recommending instead that patients first.
Alternatives
Setting: It is an outpatient, office-based procedure available primarily through private aesthetic, cosmetic, or women's wellness clinics [29, 30].
Safety checklist
Safety checklist
Use these questions to decide whether treatment should be discussed, delayed or redirected.
Has the cause been assessed?
Symptoms should be reviewed in context before selecting a treatment.
Are red flags absent?
Safety Profile: Because PRP uses autologous (the patient's own) blood, there is a minimal risk of allergic reaction or foreign body rejection [5, 18].
Are alternatives clear?
Setting: It is an outpatient, office-based procedure available primarily through private aesthetic, cosmetic, or women's wellness clinics [29, 30].
Is follow-up planned?
The clinic should explain aftercare, review timing and when to seek help.
Reassuring signs
Proceeding is more reasonable when goals are clear, red flags have been checked, and expectations are realistic.
No red flags
Follow-up plan
Reasons to pause
Safety Profile: Because PRP uses autologous (the patient's own) blood, there is a minimal risk of allergic reaction or foreign body rejection [5, 18].
Bleeding
Infection
When to escalate
When to seek medical help
Some symptoms should be assessed before any elective intimate treatment. Use NHS 111 online
Severe or worsening pain
Safety Profile: Because PRP uses autologous (the patient's own) blood, there is a minimal risk of allergic reaction or foreign body rejection [5, 18].
Bleeding or discharge
Common Side Effects: Patients may experience temporary mild swelling, bruising, brief burning sensations, spotting, or mild dysuria (pain during urination) [19-21].
Infection signs
Red Flags & Contraindications: The procedure should be avoided by pregnant or breastfeeding women, those with active vaginal or urinary tract infections, undiagnosed post-menopausal bleeding, platelet/bleeding disorders.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain or breathing difficulty.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
More clinical detail
Benchmark positioning
- The best page is clinically sharper than competitor pages because it defines SUI first and positions PRP within a full care pathway.
Clinical reality
- Patient Selection: PRP shows the more consistent reported response in women with mild to moderate SUI [1, 2].
- Regulatory Stance: Leading health bodies (such as the NHS, NICE, and RCOG) do not currently endorse PRP as a standard treatment for SUI, recommending instead that patients first exhaust conventional conservative measures (like pelvic.
- Evidence Limitations: While short-term outcomes are early, the treatment lacks large-scale, long-term randomised controlled trials to confirm durability, and results can vary significantly among individuals [27, 28].
Timeline and expectations
- Procedure Duration: The entire process, including the blood draw, centrifugation, and injection, takes approximately 30 to 45 minutes [12, 13].
- Onset of Results: Patients typically begin noticing initial improvements in 1 to 3 weeks, with best reported response developing over 1 to 3 months as collagen production and tissue remodelling increase [14-16].
- Duration of Effect: Results generally last between 6 and 18 months, and maintenance treatments may be required to sustain the continence effects [15, 17, 18].
Practical logistics
- Setting: It is an outpatient, office-based procedure available primarily through private aesthetic, cosmetic, or women's wellness clinics [29, 30].
- Costs should be confirmed on the /pricing/ page before booking
- Downtime: There is usually little recovery time; most women can resume normal daily activities and sexual intercourse immediately or within a few days [13, 34, 35].
Research sources
- Saraluck A. et al.
- Athanasiou S. et al.
- Jiang YH. et al.
- Ashton L. et al.
Regulatory resources
Authoritative resources
These resources support assessment-led, evidence-aware patient information.
NICE guidance on vaginal laser for urogenital atrophy
NICE is a UK authority for interventional procedure governance and supports cautious language about evidence, consent and audit.
FDA safety communication on vaginal rejuvenation devices
This safety communication is a useful regulatory reference for avoiding over-claiming around sexual enhancement procedures.
RCOG patient information on menopause symptom treatment
RCOG patient information supports assessment-led discussion of vaginal dryness, discomfort and hormone-related symptoms.
Next step
Book a clinical consultation
A consultation can confirm whether this treatment may be suitable, whether another pathway should come first, and what realistic outcomes and aftercare would look like.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 124 imported records. Additional reviewed material included UK clinical guidance, peer-reviewed clinical papers, evidence reviews, clinical trial records; duplicate, low-relevance and non-clinical records were removed before display.
Educational only. This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. [30]. PRP for SUI is considered an experimental, off-label procedure by major regulatory bodies. Always consult with a qualified healthcare provider or urogynaecologist to properly diagnose incontinence and discuss evidence-based treatment options. [3, 26] Results vary. Not a cure.
